Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer

Future Virol. 2021 Jun:10.2217/fvl-2021-0072. doi: 10.2217/fvl-2021-0072. Epub 2021 Jun 30.

Authors

Roy Chebel¹, Chris Labaki¹, Maria Farhat¹, Joseph Kattan¹

Affiliation

¹ Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon.

No abstract available

Keywords: COVID-19; SARS-CoV-2; cancer; immunogenicity; vaccines.

Publication types

Editorial